In conclusion, the present meta-analysis provides clear evidence that the PIN1 promoter polymorphism (−842 G>C) contributes to a decreased cancer risk, supporting the hypothesis that the polymorphism may present as a biomarker for susceptibility to cancer. This evidence concerns the gene PIN1 and cancer.